Pharmaceutical proteomics

Annals of the New York Academy of Sciences

Volumn 919, Issue , 2000, Pages 48-51

  Steiner, Sandra ^a   Leigh Anderson, N ^a  

^a Large Scale Biology Corporation   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 [(4 CHLOROPHENOXY)METHYL] 7A (3,4 DICHLOROPHENYL)TETRAHYDROPYRROLO[2,1 B]OXAZOL 5(6H) ONE; ANTIDIABETIC AGENT; ANTILIPEMIC AGENT; COLESTYRAMINE; CYCLOSPORIN; DRUG; ETOMOXIR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PEROXISOME PROLIFERATOR; UNCLASSIFIED DRUG;

CONFERENCE PAPER; DRUG SAFETY; LIVER TOXICITY; NEPHROTOXICITY; NONHUMAN; PROTEIN ANALYSIS; PROTEIN EXPRESSION; TOXICITY TESTING;

EID: 0033711163     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2000.tb06866.x     Document Type: Conference Paper

References (9)

1. Hypolipidemic hepatic peroxisome proliferators form a novel class of chemical carcinogens
2. Control of the peroxisomal β-oxidation pathway by a novel family of nuclear hormone receptors
3. The effects of peroxisome proliferators on protein abundances in mouse liver
4. New insights into cyclosporine A nephrotoxicity by proteome analysis
5. Cyclosporine A mediated decrease in the rat renal calcium binding protein calbindin-D 28kDa
6. Decrease in kidney calbindin-D as a possible mechanism mediating CsA and FK-506-induced calciuria and tubular mineralization
7. Changes in the liver proteome of female Wistar rats treated with the hypoglycemic agent SDZ PGU 693
8. A two-dimensional gel database of rat liver proteins useful in gene regulation and drug effects studies
9. Induction of the adipose differentiation-related protein in liver of etomoxir treated rats